Is this you? Create Your Porfile
Avatar

Arnold Harry Ratcliffe

Imperial Chemical Industries

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Arnold Harry Ratcliffe is active.

Explore More

Publication

Featured researches published by Arnold Harry Ratcliffe.

Journal of Medicinal Chemistry | 1992

New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties and structure-activity relationships of 2-alkylbenzimidazole derivatives

Andrew Peter Thomas; Christopher P. Allott; Keith Hopkinson Gibson; John S. Major; Brian B. Masek; Alec A. Oldham; Arnold Harry Ratcliffe; David Anthony Roberts; Simon Thomas Russell; Douglas A. Thomason

Journal of Medicinal Chemistry | 1992

New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)pyridine derivatives

Robert Hugh Bradbury; Christopher P. Allott; Michael Dennis; J. Alan Girdwood; Peter W. Kenny; John S. Major; Alec A. Oldham; Arnold Harry Ratcliffe; Janet E. Rivett

Archive | 1993

1,6-naphthyridinone derivatives having angiotension II antagonist activity

Arnold Harry Ratcliffe; Robert James Pearce; Keith H. Gibson; Robin Wood; Brian B. Masek

Archive | 1992

Pyridine and quinoline derivatives, processes for their manufacture and their use as angiotensin II antagonists

Robert Hugh Bradbury; Martin Paul Edwards; Arnold Harry Ratcliffe

Archive | 1991

Angiotensin ii antagonizers which are condensed pyridine derivatives

David A. Roberts; Arnold Harry Ratcliffe; Robert H. Bradbury

Journal of Medicinal Chemistry | 1990

1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 1. Synthesis and biological properties of alkyl alcohol and statine derivatives

David Anthony Roberts; Robert Hugh Bradbury; Brown D; Faull A; Griffiths D; Major Js; Oldham Aa; Pearce Rj; Arnold Harry Ratcliffe; Revill J

Archive | 1992

1,6-naphthyridone derivatives having angiotensin ii antagonist activity

Arnold Harry Ratcliffe; Robert James Pearce; Keith H. Gibson; Robin Wood; Brian B. Masek

Archive | 1992

Pyridinyl compounds which are useful as angiotensin ii antagonists

Robert H. Bradbury; Martin Paul Edwards; Arnold Harry Ratcliffe

Archive | 1993

Heterocyclic compounds as angiotensin ii antagonists

Arnold Harry Ratcliffe; Keith Hopkinson Gibson

Archive | 1992

PYRIDINE COMPOUNDS WHICH ARE USEFUL AS ANGIOTENSIN II RECEPTOR ANTAGONISTS

David A. Roberts; Robert H. Bradbury; Martin Paul Edwards; Arnold Harry Ratcliffe

Explore More

Collaboration

Dive into the Arnold Harry Ratcliffe's collaboration.

Top Co-Authors
Avatar

Martin Paul Edwards

Imperial Chemical Industries

View shared research outputs
Top Co-Authors
Avatar

Robert Hugh Bradbury

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Keith Hopkinson Gibson

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Robert H. Bradbury

Imperial Chemical Industries

View shared research outputs
Top Co-Authors
Avatar

Robert James Pearce

Imperial Chemical Industries

View shared research outputs
Top Co-Authors
Avatar

Robin Wood

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

David Anthony Roberts

Pfizer

View shared research outputs
Top Co-Authors
Avatar

David A. Roberts

Imperial Chemical Industries

View shared research outputs
Top Co-Authors
Avatar

Simon Thomas Russell

Imperial Chemical Industries

View shared research outputs
Top Co-Authors
Avatar

Brian B. Masek

Wilmington University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge